Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial

October 22, 2013 updated by: Hospital Authority, Hong Kong
The aims of this study are (1) to examine the effect of smoking reduction intervention (reduction counseling and nicotine replacement therapy, NRT) (a) on smoking cessation and (b) on reducing daily cigarette consumption among smokers not willing to quit smoking but want to reduce smoking, and (2) to examine the effect of adherence intervention in producing a higher (a) adherence rate, (b) reduction rate, and (c) quit rate.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

3826

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • The University of Hong Kong
      • Hong Kong, China
        • HAHO
      • Hong Kong, China
        • Hong Kong Council on Smoking and Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 or above
  • Ethnic Chinese male or female
  • Smokes at least 2 cigarettes per day
  • Have no intention to quit in the near future
  • Intends to reduce smoking in the next 7 days
  • Has no contraindication to NRT

Exclusion Criteria:

  • Subjects who are psychologically or physically unable to communicate
  • Children and teenagers (age below 18)
  • Pregnant or intention to become pregnant within the next 6 months
  • Those on regular psychotropic medications and in the presence of any serious health problems that may make them unsuitable for using NRT, such as recent stroke, palpitation, or other life threatening conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
quit rate
Time Frame: 6 months
6 months
Reduction Rate (reduction of cigarette consumption by at least 50% compared with baseline)
Time Frame: 6 months
6 months
Adherence Rate to NRT
Time Frame: 4 weeks
4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Validated quit rate (by measuring exhaled CO and urinary cotinine level)
Time Frame: 6 months
6 months
Quit rate without validation
Time Frame: 1 month
1 month
self-reported use of NRT for at least 4 weeks or 8 weeks, without cotinine validation
Time Frame: 1 month / 3 month
1 month / 3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: TH Lam, Prof, Department of Community Medicine, Faculty of Medicine, The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2004

Study Completion (Actual)

July 1, 2006

Study Registration Dates

First Submitted

November 21, 2007

First Submitted That Met QC Criteria

November 23, 2007

First Posted (Estimate)

November 26, 2007

Study Record Updates

Last Update Posted (Estimate)

October 23, 2013

Last Update Submitted That Met QC Criteria

October 22, 2013

Last Verified

October 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • UW 03-103 T/103
  • HARECCTR0500051

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe